LAFUTIDINE

LAFUTIDINE

Biochem/physiol Actions

Lafutidine is a second generation H2 histamine receptor antagonist. Lafutidine has been used clinically to treat ulcers and gastro-esophageal reflux disease (GERD). Lafutidine has also been investigated as a treatment against peripheral neuropathy and for its protective stomach effects during cancer chemotherapies and long term ibuprofen use.

Packaging

10, 50 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Solubility Form Assay Price Quantity
3575154 LAFUTIDINE white to beige 100 KMZQAVXSMUKBPD-DJWKRKHSSA-N 1S/C22H29N3O4S/c26-21(18-30(27)17-20-7-6-14-28-20)23-9-2-5-13-29-22-15-19(8-10-24-22)16-25-11-3-1-4-12-25/h2,5-8,10,14-15H,1,3-4,9,11-13,16-18H2,(H,23,26)/b5-2 SIGMA-ALDRICH DMSO: 20 mg/mL, clear powder ≥98% (HPLC)
£108.50 (exc VAT) per 10MG
-
+
3575155 LAFUTIDINE white to beige 100 KMZQAVXSMUKBPD-DJWKRKHSSA-N 1S/C22H29N3O4S/c26-21(18-30(27)17-20-7-6-14-28-20)23-9-2-5-13-29-22-15-19(8-10-24-22)16-25-11-3-1-4-12-25/h2,5-8,10,14-15H,1,3-4,9,11-13,16-18H2,(H,23,26)/b5-2 SIGMA-ALDRICH DMSO: 20 mg/mL, clear powder ≥98% (HPLC)
£240.96 (exc VAT) per 50MG
-
+